Palomino Laboratories Inc.
PALX· OTC
PALXPalomino Laboratories Inc.
Quarterly figures for Palomino Laboratories Inc., with source filings when available.
16 quarters. Jun 30, 2022 to Jun 30, 2026. mixed units.
Palomino Laboratories Inc. has filed its 10-Q within 36 to 45 days of period end across its last 8 quarters. The 10-K runs 87 to 92 days.
Palomino Laboratories Inc. · CIK 1938569 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 5, 2026 | 36 d | 10-Q | — | — | -$0.06 | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | — | — | -$0.07 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Mar 31, 2026 | 90 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 14, 2025 | 45 d | 10-Q | ||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 28, 2025 | 87 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | 45 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 1, 2024 | 92 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 14, 2023 | 45 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q3 2022 | Sep 30, 2022 | — | — | — | — | — | — | -$0.00 | |
| Q2 2022 | Jun 30, 2022 | — | — | — | — | — | — | — | |
| — |
| — |
| -$0.54 |
| Q2 2025 | Jun 30, 2025 | — | Aug 7, 2025 | 38 d | 10-Q | — | — | $0.15 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | — | — | -$0.44 |
|---|
| — |
| — |
| $0.00 |
| Q2 2024 | Jun 30, 2024 | — | Aug 14, 2024 | 45 d | 10-Q | — | — | -$0.01 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | — | — | -$0.01 |
|---|
| — |
| — |
| -$0.01 |
| Q2 2023 | Jun 30, 2023 | — | — | — | — | — | — | -$0.00 |
|---|
| Q1 2023 | Mar 31, 2023 | — | — | — | — | — | — | -$0.00 |
|---|
